#RNL2024 @philseo: I now give Tociliizumab for nearly all patients with GCA GiACTA shows we weren't doing well enough w/steroid monotherapy GiACTA shows dosing frequency does not make big diff in new diagnosis, but makes a diff in relapsing disease https://t.co/khJe0bwKXy